Predictive Markers Require Thorough Analytic Validation
Megan L. Troxell(Stanford University), Yaping Wu(Nanjing Medical University), Thomas Haas(St. Francis Hospital), Jingxin Qiu(University of Florida), Abiy B. Ambaye(University of Vermont), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Patrick L. Fitzgibbons(Good Samaritan Hospital), Andrew M. Bellizzi(University of Iowa), Dylan V. Miller(Roche (Switzerland)), Paul E. Swanson(University of Washington), Jeffrey D. Goldsmith(Beth Israel Deaconess Medical Center), Robert A. Schwartz(Rutgers, The State University of New Jersey), Dennis P. O’Malley(Ambry Genetics (United States)), Kurt B. Schaberg(UC Davis Health), Jinru Shia(Memorial Sloan Kettering Cancer Center), Thomas A. Summers(Walter Reed National Military Medical Center), Regan Fulton(Program for Appropriate Technology in Health), Patti Loykasek
Cited by 1
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2010|898